Sponge hemostatic agent SURGISPON®

neurosurgery

Overview
Absorbable haemostatic products for neurosurgery: SURGISPON® (absorbable gelatin sponge & powder), SURGI-ORC® (oxidized regenerated cellulose) and FLOGEL® (flowable gelatin haemostatic matrix). Designed to provide rapid, secure haemostasis in irregular cavities and narrow fields, reduce intraoperative bleeding and support surgical efficiency.

SURGISPON® – Absorbable Haemostatic Gelatin Sponge & Powder

• Absorbable gelatin sponge that achieves rapid local haemostasis.
• Uniform porosity for effective clot formation and fluid uptake.
• Absorbs approximately 45× its weight in water/oxalate blood.
• Provides structural support to stabilize clot at the bleeding site.
• pH-neutral, compatible with adjuncts such as thrombin or drugs.
• Completely resorbed within ~4 weeks.
• Available in sponge and powder/putty variants for cancellous bone bleeding control.

Key features & benefits (SURGISPON®)

• Fast, reliable haemostasis on soft tissue and bone surfaces.
• Conforms to irregular anatomy.
• Powder/putty options for trabecular bone oozing.

Indications (SURGISPON®)

• Haemostasis of dural, epidural, bone, parenchymal and skull bleeding.
• Dural reconstruction following trauma or tumor resection.
• Supplementary use in vascular repair and implant fixation.

SURGI-ORC® – Oxidized Regenerated Cellulose

• Plant-derived absorbable haemostat suitable for capillary, venous and minor arterial bleeding.
• Creates a low-pH environment with bactericidal properties.
• Resorbed within ~7–14 days.
• Highly drapable and pliable—suitable for deep or narrow operative fields.
• Acts as an anti-adhesive barrier and conforms to tissue without instrument adherence.
• Available in multiple formats: Original/Standard, Knit, Fibril, Non-woven/Snow and Powder.

Key features & benefits (SURGI-ORC®)

• Natural plant-based origin with secure haemostasis.
• Low pH confers localized bactericidal effect.
• Good coverage and handling in confined spaces.

Indications (SURGI-ORC®)

• Arterial, dural and venous bleeding including cavernous sinus and venous plexus.
• Use in various cranial procedures: ELITE exposures, lateral suboccipital craniotomy, microvascular decompression, craniotomy/craniectomy.
• Posterior fossa tumor resections, chronic subdural haematoma, intracranial meningiomas, AVM and cavernoma surgeries.

FLOGEL® – Flowable Gelatin Haemostatic Matrix Kit

• Flowable, absorbable gelatin matrix supplied as a prefilled syringe for application into tight or irregular cavities.
• Designed for difficult-to-reach bleeding sites and cavity oozing.
• Quick preparation with uniform viscosity and an effective working time of up to ~8 hours.
• Ensures firm contact and adherence to the application site for faster haemostasis.
• Conforms to tissue contours and remains in crevices during active bleeding; excess can be irrigated once haemostasis is achieved.
• Biocompatible and resorbed within ~4 weeks.

Key features & benefits (FLOGEL®)

• Rapid preparation and consistent handling characteristics.
• Extended working time and strong adherence to target site.
• Effective in irregular cavities and deep operative fields.
• Biocompatible and resorbable.

Indications (FLOGEL®)

• Tumor resection cavities with large raw surfaces or cavity oozing.
• Skull base procedures including tumor bed and sinus management, transsphenoidal approaches.
• Application in AVM resection cavities and other narrow/irregular surgical sites.

Packaging & Variants

• Multiple formats across the range: sponge sheets (various textures), powder/putty for cancellous bone, flowable prefilled syringe kits, and varied carton/pack sizes.

Technical specifications

• Absorbency: SURGISPON® ~45× its own weight.
• Absorption time: SURGISPON® ~4 weeks; FLOGEL® ~4 weeks; SURGI-ORC® ~7–14 days.
• pH: SURGISPON® neutral (compatible with adjuncts); SURGI-ORC® low pH (bactericidal).
• Biocompatibility: Non-toxic, non-allergenic, non-immunogenic, non-pyrogenic where stated.
• Forms: sponge sheets, powder/putty, flowable syringe; multiple structural variants for surgical needs.